RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports First Quarter 2024 Financial Results
RAPT Therapeutics | DEFA14A: Others
RAPT Therapeutics | DEF 14A: Definitive information statements
RAPT Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Third Quarter 2023 Financial Results
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | S-3: Registration statement for specified transactions by certain issuers
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Second Quarter 2023 Financial Results
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | DEFA14A: Others
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports First Quarter 2023 Financial Results
RAPT Therapeutics | DEFA14A: Others
RAPT Therapeutics | DEF 14A: Definitive proxy statements
RAPT Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
No Data